期刊文献+

HPV分型联合TCT检测在宫颈疾病中的诊断价值 被引量:3

Diagnostic value of HPV typing combined with TCT detection in cervical diseases
下载PDF
导出
摘要 目的探讨人乳头瘤病毒(HPV)分型、液基薄层细胞学(TCT)技术及二者联合检测在宫颈疾病中的诊断价值。方法回顾性分析257例患者行HPV分型检测及TCT检查的检查结果数据,以病理检查结果作为阳性诊断金标准并进行分析。结果 257例患者中82例病理检查结果为阳性。HPV分型、TCT及二者联合检测筛查的灵敏度分别为89.02%、75.61%、71.95%;特异度分别为56.57%、72.57%、88.00%;阳性预测值分别为48.99%、56.36%、73.75%;诊断准确度分别为66.93%、73.54%、82.88%。二者联合检测的特异度、阳性预测值、诊断准确度都明显高于二者单独检测,差异有统计学意义(P<0.05)。高危型HPV检出率为42.03%,其中HPV-16检出率最高,检出率为16.73%。结论 HPV分型和TCT联合检测能够提高检出的阳性符合率,建议二者联合应用于宫颈疾病的筛查。 Objective To explore the diagnostic value of human papillomavirus(HPV)typing,thinprep cytology test(TCT)technology and their combination detection in cervical diseases.Methods The results data in 257 patients undergoing HPV typing and TCT examination were retrospectively analyzed with the pathological examination results as the gold standard of positive diagnosis.Results Among 257 cases,82cases had positive pathological examination results.The sensitivities of HPV typing,TCT and their combined detection were 89.02%,75.61%and 71.95%respectively.The specificities were 56.57%,72.57% and 88.00%respectively.The positive predictive values were 48.99%,56.36% and 73.75%respectively;the diagnostic accuracies were 66.93%,73.54% and 82.88%respectively.The specificity,positive predictive value and diagnostic accuracy of their combined detection were significantly higher than those of single item detection,the difference was statistically significant(P〈0.05).The detection rate of high risk type HPV was 42.03%,the detection rate of HPV-16 was highest,which was 16.73%.Conclusion HPV typing and its combined detection with TCT can improve the positive coincidence rate.It is suggested that the their combined application can be used in the screening of cervical diseases.
作者 李磊 余汉忠 马萍 LI Lei YU Hanzhong MA Ping(Medical Technology College, Xuzhou Medical University, Xuzhou, Jiangsu 221002, China Department of Clinical Laboratory, Xuzhou Municipal Third People's Hospital, Xuzhou, Jiangsu 221002, China Department of Clinical Laboratory, Xuzhou Municipal First People's Hospital, Xuzhou, Jiangsu 221002, China)
出处 《国际检验医学杂志》 CAS 2017年第3期337-338,341,共3页 International Journal of Laboratory Medicine
关键词 宫颈疾病 人乳头瘤病毒分型 液基薄层细胞学 cervical diseases human papillomavirus typing thinprep cytology test
  • 相关文献

参考文献3

二级参考文献29

  • 1王华,陈亚宝,叶丽华,叶军,袁冬兰.应用支链DNA技术检测人乳头瘤病毒E6/E7mRNA在宫颈疾病筛查中的价值[J].中华临床医师杂志(电子版),2011,5(15):4362-4366. 被引量:29
  • 2赵昀,崔淑慧,任丽华,赵超,魏丽惠.细胞学、HPV高危型检测在宫颈病变筛查中的应用[J].中国妇产科临床杂志,2006,7(2):89-93. 被引量:58
  • 3何桂蓉,何林,李芳芳,刘忠.人乳头瘤病毒感染分子诊断的研究进展[J].中华检验医学杂志,2006,29(11):1048-1049. 被引量:7
  • 4何桂蓉,刘忠.高危型HPV型别、病毒载量与宫颈癌前病变的相关性研究[J].现代检验医学杂志,2007,22(4):32-35. 被引量:22
  • 5Solomon D.Bethesda system 2001.Acta Cytologica,2001,46:6-7.
  • 6Chellappan S, Kraus VB, Kroger B, et al, AdenoVirus E1 A, simian Virus 40 tumor antigen, and human Papilloma Virus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product [J] . Proc Nati Acad Sci USA, 1992,89(10): 4549-4553.
  • 7Benevolo M, Vocaturo A, Caraceni D, et al. Sensitivity, specificity, and clinical value of human Papilloma Virus (HPV) E6/E7 mRNA assay as a triage test for cervical cytology and HPV DNA test [J]. J Clin Microbiol, 2011,49(7): 2643-2650.
  • 8Benevolo M, Terrenato I, Mottolese M, et al. Diagnostic and prognostic validity of the human Papilloma Virus E6/E7 mRNA test in cervical cytological samples of HC2-positive patients [J] . Cancer Causes Control, 2011,22(6): 869-875.
  • 9von Knebel Doeberitz M. New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic Papilloma Virus infections [J]. Eur J Cancer, 2002, 38 ( 17 ) : 2229-2242.
  • 10Liu TY, Xie R, Luo L, et al. Diagnostic validity of human papillomavirus E6/E7 mRNA test in cervical cytological samples [J]. J Virol Methods, 2014,196: 120-125.

共引文献67

同被引文献25

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部